Therapeutic equivalence and early onset of action of a novel water-soluble budesonide nasal spray (Budesolv 10) compared to Rhinocort® aqua 64 in patients suffering from grass pollen induced allergic rhinitis with or without asthma

MLA

Nicole Unger-Manhart, et al. “Therapeutic Equivalence and Early Onset of Action of a Novel Water-Soluble Budesonide Nasal Spray (Budesolv 10) Compared to Rhinocort® Aqua 64 in Patients Suffering from Grass Pollen Induced Allergic Rhinitis with or without Asthma.” World Allergy Organization Journal, vol. 13, no. 8, Aug. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....316d0d37479c553aca471ce922fe9db4&authtype=sso&custid=ns315887.

APA

Nicole Unger-Manhart, Petra Zieglmayer, Patrick Lemell, Eva Prieschl-Grassauer, René Zieglmayer, & Andreas Goessl. (2020). Therapeutic equivalence and early onset of action of a novel water-soluble budesonide nasal spray (Budesolv 10) compared to Rhinocort® aqua 64 in patients suffering from grass pollen induced allergic rhinitis with or without asthma. World Allergy Organization Journal, 13(8).

Chicago

Nicole Unger-Manhart, Petra Zieglmayer, Patrick Lemell, Eva Prieschl-Grassauer, René Zieglmayer, and Andreas Goessl. 2020. “Therapeutic Equivalence and Early Onset of Action of a Novel Water-Soluble Budesonide Nasal Spray (Budesolv 10) Compared to Rhinocort® Aqua 64 in Patients Suffering from Grass Pollen Induced Allergic Rhinitis with or without Asthma.” World Allergy Organization Journal 13 (8). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....316d0d37479c553aca471ce922fe9db4&authtype=sso&custid=ns315887.